TMEM30A plays a role in the survival of hematopoietic cells [115], and TMEM30A gene knockdown improves chemotherapy treatment outcomes in diffuse large B-cell lymphoma [116]. This evidence concerns the gene CDC50A and diffuse large B-cell lymphoma.